EP2540349
PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.7.2009EP published:
12.2.2014EP application number:
12181533.6
EPO information:
European Patent Register
Max expiry date:
16.7.2029
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR
Timeline
Today
17.7.2009EP application
12.2.2014EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, 07065, Rahway, NJ, US
Name:
MSD Italia S.r.l.Address:
Via Vitorchiano, 151, 00189, Rome, IT
Inventor
Name:
Harper, StevenAddress:
Rome, IT
Name:
Summa, VincenzoAddress:
Rome, IT
Name:
Liverton, Nigel J.Address:
Rahway, NJ New Jersey, US
Name:
McCauley, John A.Address:
Rahway, NJ New Jersey, US
Priority
Number:
135559 PDate:
22.7.2008Country:
US
Classification
Categories:
A61P 31/14, A61K 38/06, A61K 38/07, A61K 38/08, C07K 5/08, C07K 5/10, C07K 5/12